lncRNA p53 regulated and ESC associated 1Genealiases: []
Q-omics provides the consensus-scored LNCPRESS1 profile across patient tissues and cancer cell-line models. LNCPRESS1 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in LIHC. Among the 18 cancer types available for tumor–normal comparison, LNCPRESS1 is differentially expressed in 2, with the highest sampling consensus in KICH. Additionally, LNCPRESS1 RNA expression shows 7,070 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight LIHC, KICH, and TGCT as cancer lineages where LNCPRESS1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LNCPRESS1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LNCPRESS1 survival associations across molecular data types. LNCPRESS1 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LNCPRESS1 RNA expression–survival associations across cancer types. High LNCPRESS1 expression shows unfavorable associations in SKCM, LUAD and COAD, but favorable associations in LIHC, HNSC and LAML. The LIHC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify LIHC as the clearest survival context for LNCPRESS1 RNA expression.
This table summarizes LNCPRESS1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in LIHC for RNA.
This table ranks reproducible tumor–normal expression differences for LNCPRESS1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LNCPRESS1 shows lower tumor expression in LIHC and higher tumor expression in KICH. The KICH box plot shows higher LNCPRESS1 RNA expression in tumor versus normal tissue (log2 FC = +0.075, t-test p = .023).
This table shows molecular features associated with LNCPRESS1 in patient tissues and cancer cell lines. In patient samples, LNCPRESS1 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
